Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy

References

• Kumar R, Biggart JD, McEvoy J, McGeown MG. Cyclopho-sphamide and reproductive function. Lancet 1972;1:1212–14.
   PubMed Web of Science ®Google Scholar
• Uldall PR, Kerr DNS, Tacchi D. Sterility and cyclopho-sphamide. Lancet 1972;1:693–4.
   Google Scholar
• Rose DP, Davis TE. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet 1977;1: 1174–6.
   PubMed Web of Science ®Google Scholar
• Warne GL, Fairley KF, Nobbs JB, Martin FL. Cyclopho-sphamide induced ovarian failure. N Engl J Med 1973; 289:1159–62.
   PubMed Web of Science ®Google Scholar
• Lu CC, Meistrich M. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res 1979;39:3575–82.
   PubMed Web of Science ®Google Scholar
• Chapman RI\4, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. J Am Med Assoc 1979;242:877–81.
   Google Scholar
• Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377–82.
   PubMed Web of Science ®Google Scholar
• Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. J Am Med Assoc 1988;259:2123–5.
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Human Reprod 1996;11:1620–6.
   Google Scholar
• Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997;29:199–206.
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Ritter M, Shen-Orr Z, Shariki K, Ben-Shahar M, Haim N. Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity. Am J Reprod Immunol 1998;39:33–40.
   Google Scholar
• Blumenfeld Z. Preservation of ovarian function in young women undergoing chemotherapy. Gynecol Endocrinol 1999;13\(Suppl 1):abstract 66.
   Google Scholar
• Miller JJ, Williams GF, Leissring JC. Multiple late complica-tions of therapy with cyclophosphamide, including ovarian destruction. Am J Med 1971;50:530–5.
   Google Scholar
• Schilsky RL,, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 1981;71:552–6.
   PubMed Web of Science ®Google Scholar
• Ataya 1KI\4, Pydyn EF, Ramahi-Ataya AJ. The effect of 'activated' cyclophosphamide on human and rat ovarian granulosa cells in vitro. Reprod Toxicol 1990;4:121–5.
   PubMed Web of Science ®Google Scholar
• Ataya KM, McKanna JA, Weintraub AM, Clark MR, LeMaire WJ. A luteinising hormone-releasing hormone agonist for the prevention of chemotherapy included ovarian follicular loss rats. Cancer Res 1985;45:3651–6.
   Google Scholar
• Pennisi AJ, Grushkin CM, Lieberman E. Gonadal function in children with nephrosis treated with cyclophosphamide. Am J Dis Child 1975;129:315–18.
   Google Scholar
• Wallace WH, Shalet SM, Tetlow U, Morris-Jones PH. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 1993;21:333–9.
   Google Scholar
• Glode LM, Robinson J, Gould SF. Protection from cyclopho-sphamide-induced testicular damage with any analogue of gonadotrophin-releasing hormone. Lancet 1981;i:1132–4.
   Google Scholar
• Johnson DH, Linde R, Hainsworth JD, Val W, Rivier J, Stein R, Flexner J, van Welch R, Greco FA. Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations. Blood 1985;65:832–6.
   Google Scholar
• Ataya KM, Palmer KC, Blacker CM, Moghisi KS, Moham-mad SH. Inhibition of rat ovarian 3H-thymidine uptake by LHRH agonists: a mechanism of preventing damage by cytotoxic agents. Cancer Res 1988;48: 7252–6.
   Google Scholar
• Fox KR, Ball JE, Mick R, Moore HC. Preventing chemother-apy-associated amenorrhea (CRA) with leuprolide in young women with early-stage breast cancer [abstract]. In: Granberg SM, editor. Proceedings of the Thirty-seventh Annual Meet-ing of the American Society of Clinical Oncology; 2001 May; San Francisco: American Society of Clinical Oncology; 2001. Abstract 98.25a p.
   Google Scholar
• Pereyra Pacheco B, Mendez Ribas JM, Milone G, Fernandez I, Kvicala R, Mila T, Di Noto A, Contreras Ortiz O, Pavlovsky S. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 2001; 81:391–7.
   PubMed Web of Science ®Google Scholar
• Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A, Dennerstein L. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Chin Endocrinol (Oxf) 1998;48:809–13.
   Google Scholar
• Franke HR, van de Weijer PHM, Pennings TMM, van der Mooren MJ. Gonadotropin-releasing hormone agonist plus 'add-back' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial. Fertil Steril 2000;74:534–9.
   PubMed Web of Science ®Google Scholar
• Chapman RM, Sittcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 1981;58:849–51.
   PubMed Web of Science ®Google Scholar
• Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983;52:988–93.
   PubMed Web of Science ®Google Scholar
• Raff M. Social controls on cell survival and cell death. Nature 1992;356:397–9.
   PubMedGoogle Scholar
• Scheffer G. Assessment of reproductive aging in normal women [thesis]. Utrecht: University of Utrecht; 2000.
   Google Scholar
• Kakar SS, Grizzle WE, Neill JD. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary. Mol Cell Endocrinol 1994;106:145–9.
   Google Scholar